Nevirapine

Chemical formula: C₁₅H₁₄N₄O  Molecular mass: 266.298 g/mol  PubChem compound: 4463

Therapeutic indications

Nevirapine is indicated for:

HIV-1 infection

Population group: only children (1 year - 12 years old)

Nevirapine is indicated in combination with other anti-retroviral medicinal products for the treatment of HIV-1 infected children of any age.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

HIV-1 infection

Population group: only adolescents (12 years - 18 years old) , adults (18 - 65 years old)

Nevirapine is indicated in combination with other anti-retroviral medicinal products for the treatment of HIV-1 infected adults and adolescents.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Nevirapine is contraindicated in the following cases:

St. John's Wort (Hypericum perforatum)

Hypericum perforatum (St John's Wort)

Severe hepatic impairment (Child-Pugh C)

Hepatic failure stage IV

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: NEVIRAPINE TEVA Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈